Aquigen Bio Science
Hyderabad, India· Est.
A contract‑research partner delivering custom API synthesis, impurity standards and deuterated compounds for accelerated drug development.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
A contract‑research partner delivering custom API synthesis, impurity standards and deuterated compounds for accelerated drug development.
OncologyCardiovascularMetabolicInfectious DiseasesNutraceuticals
Technology Platform
Advanced synthetic chemistry and analytical services, including custom API/Intermediate synthesis, impurity isolation, deuterium labeling, and peptide impurity standard production.
Opportunities
Rising demand for impurity standards and deuterated compounds in regulatory submissions, and the cost advantage of Indian manufacturing, create strong growth potential.
Risk Factors
Regulatory changes, intense competition from global reference‑standard suppliers, and reliance on pharma R&D spending could affect revenue stability.
Competitive Landscape
Competes with established providers like Sigma‑Aldrich, Thermo Fisher, and Cambrex; differentiates through integrated custom synthesis and analytical validation within a single Indian-based facility.